Baltimore News Journal – Lifestyle

Author: Tango Therapeutics Sub, Inc

Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights

May 13, 2026
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 4, 2026
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat

April 15, 2026